Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Madhvi B. Upender is active.

Publication


Featured researches published by Madhvi B. Upender.


Journal of Cell Biology | 2007

Actin-dependent intranuclear repositioning of an active gene locus in vivo

Miroslav Dundr; Jason K. Ospina; Myong Hee Sung; Sam John; Madhvi B. Upender; Thomas Ried; Gordon L. Hager; A. Gregory Matera

Although bulk chromatin is thought to have limited mobility within the interphase eukaryotic nucleus, directed long-distance chromosome movements are not unknown. Cajal bodies (CBs) are nuclear suborganelles that nonrandomly associate with small nuclear RNA (snRNA) and histone gene loci in human cells during interphase. However, the mechanism responsible for this association is uncertain. In this study, we present an experimental system to probe the dynamic interplay of CBs with a U2 snRNA target gene locus during transcriptional activation in living cells. Simultaneous four-dimensional tracking of CBs and U2 genes reveals that target loci are recruited toward relatively stably positioned CBs by long-range chromosomal motion. In the presence of a dominant-negative mutant of β-actin, the repositioning of activated U2 genes is markedly inhibited. This supports a model in which nuclear actin is required for these rapid, long-range chromosomal movements.


Cancer Research | 2004

Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells

Madhvi B. Upender; Jens K. Habermann; Lisa M. McShane; Edward L. Korn; J. Carl Barrett; Michael J. Difilippantonio; Thomas Ried

Chromosomal aneuploidies are observed in essentially all sporadic carcinomas. These aneuploidies result in tumor-specific patterns of genomic imbalances that are acquired early during tumorigenesis, continuously selected for and faithfully maintained in cancer cells. Although the paradigm of translocation induced oncogene activation in hematologic malignancies is firmly established, it is not known how genomic imbalances affect chromosome-specific gene expression patterns in particular and how chromosomal aneuploidy dysregulates the genetic equilibrium of cells in general. To model specific chromosomal aneuploidies in cancer cells and dissect the immediate consequences of genomic imbalances on the transcriptome, we generated artificial trisomies in a karyotypically stable diploid yet mismatch repair-deficient, colorectal cancer cell line and in telomerase immortalized, cytogenetically normal human breast epithelial cells using microcell-mediated chromosome transfer. The global consequences on gene expression levels were analyzed using cDNA arrays. Our results show that regardless of chromosome or cell type, chromosomal trisomies result in a significant increase in the average transcriptional activity of the trisomic chromosome. This increase affects the expression of numerous genes on other chromosomes as well. We therefore postulate that the genomic imbalances observed in cancer cells exert their effect through a complex pattern of transcriptional dysregulation.


Genes, Chromosomes and Cancer | 2007

Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis†

Jens K. Habermann; Ulrike Paulsen; Uwe J. Roblick; Madhvi B. Upender; Lisa M. McShane; Edward L. Korn; Danny Wangsa; Stefan Krüger; Michael Duchrow; Hans-Peter Bruch; Gert Auer; Thomas Ried

To identify sequential alterations of the genome, transcriptome, and proteome during colorectal cancer progression, we have analyzed tissue samples from 36 patients, including the complete mucosa‐adenoma‐carcinoma sequence from 8 patients. Comparative genomic hybridization (CGH) revealed patterns of stage specific, recurrent genomic imbalances. Gene expression analysis on 9K cDNA arrays identified 58 genes differentially expressed between normal mucosa and adenoma, 116 genes between adenoma and carcinoma, and 158 genes between primary carcinoma and liver metastasis (P < 0.001). Parallel analysis of our samples by CGH and expression profiling revealed a direct correlation of chromosomal copy number changes with chromosome‐specific average gene expression levels. Protein expression was analyzed by two‐dimensional gel electrophoresis and subsequent mass spectrometry. Although there was no direct match of differentially expressed proteins and genes, the majority of them belonged to identical pathways or networks. In conclusion, increasing genomic instability and a recurrent pattern of chromosomal imbalances as well as specific gene and protein expression changes correlate with distinct stages of colorectal cancer progression. Chromosomal aneuploidies directly affect average resident gene expression levels, thereby contributing to a massive deregulation of the cellular transcriptome. The identification of novel genes and proteins might deliver molecular targets for diagnostic and therapeutic interventions.


Oncogene | 2004

Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability

Kishore Guda; Madhvi B. Upender; Glenn S. Belinsky; Christopher Flynn; Masako Nakanishi; Jillian N. Marino; Thomas Ried; Daniel W. Rosenberg

The azoxymethane (AOM)-induced mouse colon tumor model recapitulates many of the histopathological features associated with the multistage progression of human sporadic colorectal cancers (CRCs). To better define the genetic events associated with tumorigenesis in this murine model, we analysed tumors from A/J mice for chromosomal (CIN) and microsatellite (MSI) instabilities, two fundamental pathways of genomic instability that play a critical role in the pathogenesis of human CRCs. Male A/J mice, 6-week old, were injected with either AOM (n=5) (10 mg/kg b.w., i.p.) or vehicle (n=5) (0.9% NaCl solution) once a week for 6 weeks. At 32 weeks after the last dose, comparative genomic hybridization (CGH) was performed on 16 tumors harvested from five animals. Although 25% of the tumors displayed either a gain of chromosome 2 or loss of Y, the majority (75%) showed no genomic imbalances. Further analysis of chromosomal aberrations, using CGH and spectral karyotyping (SKY) was performed in our recently established A/J colon tumor-derived cell line, AJ02-NM0. Results showed a pseudotetraploid karyotype with loss of only the Y chromosome in these cultured cells, thereby providing additional evidence for the minimal role of CIN in the primary AOM-induced tumors. Interestingly, the majority (81%) of A/J tumors displayed low-level microsatellite instability (MSI-L) when analysed using mono- and dinucleotide repeat markers, and showed a significant expansion to high-level instability (MSI-H) in the AJ02-NM0 cells. This finding in cultured cells additionally provides evidence that a mild mutator pathway may contribute to the development of behaviorally benign carcinomas in situ in A/J mice. To better understand the tumorigenic process in the A/J colons, we screened for mutational alterations in key regions of the K-ras and Apc genes. Results showed a very low frequency (6%) of K-ras activating mutations, together with the absence of Apc truncation mutations in primary tumors and AJ02-NM0 cells. However, these tumors displayed intense nuclear accumulation of β-catenin protein, indicating activation of the Wnt signaling pathway. Based on our molecular and cytogenetic findings, we propose that carcinogen-induced tumors may develop via mechanisms independent of the ‘classical’ CIN or MSI pathways.


BioTechniques | 2004

Objective method of comparing DNA microarray image analysis systems.

Edward L. Korn; Jens K. Habermann; Madhvi B. Upender; Thomas Ried; Lisa M. McShane

Many image analysis systems are available for processing the images produced by laser scanning of DNA microarrays. The image processing system takes pixel-level intensity data and converts it to a set of gene-level expression or copy number summaries that will be used in further analyses. Image analysis systems currently in use differ with regard to the specific algorithms they implement, ease of use, and cost. Thus, it would be desirable to have an objective means of comparing systems. Here we describe a systematic method of comparing image processing results produced by different image analysis systems using a series of replicate microarray experiments. We demonstrate the method with a comparison of cDNA microarray data generated by the UCSF Spot and the GenePix image processing systems.


PLOS ONE | 2007

Artificially Introduced Aneuploid Chromosomes Assume a Conserved Position in Colon Cancer Cells

Kundan Sengupta; Madhvi B. Upender; Linda Barenboim-Stapleton; Quang Tri Nguyen; Stephen Wincovitch; Susan Garfield; Michael J. Difilippantonio; Thomas Ried

Background Chromosomal aneuploidy is a defining feature of carcinomas. For instance, in colon cancer, an additional copy of Chromosome 7 is not only observed in early pre-malignant polyps, but is faithfully maintained throughout progression to metastasis. These copy number changes show a positive correlation with average transcript levels of resident genes. An independent line of research has also established that specific chromosomes occupy a well conserved 3D position within the interphase nucleus. Methodology/Principal Findings We investigated whether cancer-specific aneuploid chromosomes assume a 3D-position similar to that of its endogenous homologues, which would suggest a possible correlation with transcriptional activity. Using 3D-FISH and confocal laser scanning microscopy, we show that Chromosomes 7, 18, or 19 introduced via microcell-mediated chromosome transfer into the parental diploid colon cancer cell line DLD-1 maintain their conserved position in the interphase nucleus. Conclusions Our data is therefore consistent with the model that each chromosome has an associated zip code (possibly gene density) that determines its nuclear localization. Whether the nuclear localization determines or is determined by the transcriptional activity of resident genes has yet to be ascertained.


Analytical Cellular Pathology | 2013

Chromosomal aneuploidy affects the global proteome equilibrium of colorectal cancer cells

Timo Gemoll; Jens K. Habermann; Susanne Becker; Silke Szymczak; Madhvi B. Upender; Hans-Peter Bruch; Ulf Hellman; Thomas Ried; Gert Auer; Hans Jörnvall; Uwe J. Roblick

Background: Chromosomal aneuploidy has been identified as a prognostic factor in the majority of sporadic carcinomas. However, it is not known how chromosomal aneuploidy affects chromosome-specific protein expression in particular, and the cellular proteome equilibrium in general. Objective: The aim was to detect chromosomal aneuploidy-associated expression changes in cell clones carrying trisomies found in colorectal cancer. Methods: We used microcell-mediated chromosomal transfer to generate three artificial trisomic cell clones of the karyotypically stable, diploid, yet mismatch-deficient, colorectal cancer cell line DLD1 - each of them harboring one extra copy of either chromosome 3, 7 or 13. Protein expression differences were assessed by two-dimensional gel electrophoresis and mass spectrometry, compared to whole-genome gene expression data, and evaluated by PANTHER classification system and Ingenuity Pathway Analysis (IPA). Results: In total, 79 differentially expressed proteins were identified between the trisomic clones and the parental cell line. Up-regulation of PCNA and HMGB1 as well as down-regulation of IDH3A and PSMB3 were revealed as trisomy-associated alterations involved in regulating genome stability. Conclusions: These results show that trisomies affect the expression of genes and proteins that are not necessarily located on the trisomic chromosome, but reflect a pathway-related alteration of the cellular equilibrium.


Cancer Genetics and Cytogenetics | 2003

Pronounced chromosomal instability and multiple gene amplifications characterize ulcerative colitis–associated colorectal carcinomas

Jens K. Habermann; Madhvi B. Upender; Uwe J. Roblick; Stefan Krüger; Sandra Freitag; Harald Blegen; Hans-Peter Bruch; Hendrik Schimmelpenning; Gert Auer; Thomas Ried

Patients with ulcerative colitis have a significantly increased lifetime risk for the development of colorectal carcinomas. While genetic and genomic changes during carcinogenesis have been thoroughly studied in sporadic colorectal cancers, less is known about ulcerative colitis-associated colorectal carcinomas. The aim of this study was to extend the identification of specific genomic imbalances to ulcerative colitis-associated colorectal carcinomas and to establish a comprehensive map of DNA gains and losses by investigating 23 tumor specimens from 23 patients. The molecular cytogenetic characterization was performed using comparative genomic hybridization; immunohistochemistry was used to measure proliferative activity and laminin-5 expression as a marker for invasiveness. The results indicate that these tumors are invariably aneuploid, with a high proliferative activity and increased invasive potential. The average number of copy alterations correlates with increased cyclin A levels (P=0.044), which is an independent predictor of risk of carcinoma development in ulcerative colitis. Despite severe genetic instability, the general pattern of specific chromosomal aberrations that defines sporadic colorectal carcinomas is maintained in ulcerative colitis-associated malignancies. High-level copy number increases (amplifications) are dispersed throughout the genome. Strikingly, these amplifications are much more frequent than in sporadic carcinomas and map to chromosomal regions that have not been described before.


Advances in Experimental Medicine and Biology | 2006

From genome to proteome in tumor profiling : Molecular events in colorectal cancer genesis

Jens K. Habermann; Uwe J. Roblick; Madhvi B. Upender; Thomas Ried; Gert Auer

Biomedical research has advanced rapidly in recent years with the sequencing of the human genome and the availability of technologies such as global gene and protein expression profiling using different chip platforms. However, this progress has not yet been transferred to the bedside. While detection of cancer at early stages is critical for curative treatment interventions, efficient diagnostic and therapeutic markers for the majority of malignancies still seem to be lacking. Comprehensive tumor profiling has therefore become a field of intensive research aiming at identifying biomarkers relevant for improved diagnostics and therapeutics. This chapter will demonstrate a genomic and proteomic approach while focusing on tumor profiling during colorectal cancer development.


Archive | 2012

Aneuploidy and Epithelial Cancers: The Impact of Aneuploidy on the Genesis, Progression and Prognosis of Colorectal and Breast Carcinomas

Jens K. Habermann; Gert Auer; Madhvi B. Upender; Timo Gemoll; Hans-Peter Bruch; Hans Jörnvall; Uwe J. Roblick; Thomas Ried

Aneuploidy is a defining feature of epithelial cancers with an impact on the genesis, progression and prognosis of these malignancies. Essentially all sporadic, mismatch repair proficient colorectal carcinomas are defined by a non-random distribution of genomic imbalances. Regarding breast cancer, however, aneuploid and near diploid cases show almost similar frequencies. Independent of the tumor entity, increased levels of aneuploidy result in a worse clinical outcome. For breast and colorectal carcinomas, aneuploidy has been reported as an independent prognostic factor with an impact comparable to that of the tumor stage. Unfortunately, the translation of this knowledge into the clinic was slow. Prognostication in breast cancer is augmented by gene expression profiles of poor or good prognosis. Interestingly, there is growing evidence that prognostic gene expression signatures simply reflect the degree of genomic instability. This is not surprising since gross nuclear aneuploidy is reflected in a strikingly recurrent and tumor entity specific distribution of chromosomal imbalances. Chromosomal imbalances, in turn, do significantly modulate resident gene expression levels. Furthermore, aneuploidy also affects protein expression. Proteomics has therefore become a powerful tool to unravel potential new targets for diagnostics, prognostication and therapeutic stratification. There is also increasing evidence that aneuploidy precedes invasive disease and can already be detected in premalignant lesions such as colon adenomas and/or ulcerative colitis. It is therefore reasonable to assume that aneuploidy plays a crucial role during carcinogenesis, an interpretation consistent with its direct influence on disease outcome. This has triggered considerable efforts to elucidate how aneuploidy develops and what its impact is on the genetic equilibrium of cells at the molecular level.

Collaboration


Dive into the Madhvi B. Upender's collaboration.

Top Co-Authors

Avatar

Thomas Ried

University of Münster

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gert Auer

Karolinska Institutet

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward L. Korn

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Lisa M. McShane

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge